A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease.Â
The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy.
Neurologist and trial lead Richard Roxburgh says the method is promising.
Â
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
